Global Gene Therapy Market for CNS Disorders Projected to Reach USD 113.04 Billion by 2033 at a 30% CAGR

The global gene therapy market for central nervous system (CNS) disorders is set for remarkable growth, with an expected valuation of US$ 8.2 billion in 2023 and projected to soar to approximately US$ 113.04 billion by 2033. This growth represents a staggering compound annual growth rate (CAGR) of 30% during the forecast period from 2023 …

Gene Therapy in CNS Disorder Market Forecast 2023 to 2033 | By Type, Indication, End-Users & Region

The global Gene Therapy in CNS Disorders Market size is expected to reach US$ 8.2 billion in 2023 and US$ 103.04 billion by 2033, with a compound annual growth rate (CAGR) of 30% between 2023 and 2033. The market for gene therapy in CNS diseases grew at a 19% CAGR from 2018 to 2022. The …